Funded Tech Companies
Inversago Pharma
Based in Montreal QC, Inversago Pharma has funding from Amgen Ventures, AmorChem and Genesys Capital.
Company Overview
Company Name
Inversago Pharma
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1 Place Ville Marie 1670
Montreal QC, H3B 2B6
Canada
Montreal QC, H3B 2B6
Canada
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
A specialized, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-restricted cannabinoid-1 receptor (CB1) inverse agonists/ antagonists for the treatment of Prader-Willi Syndrome (PWS), Type-1 Diabetes (T1D), obesity and other metabolic disorders such as non-alcoholic steatohepatitis (NASH).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/17/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
François Ravenelle
Chief Financial Officer
Micheline Beauvais
Chief Medical Officer
Christine McCarthy
VP - R & D
Caroline Fradette
Company Investors
- Amgen Ventures
- AmorChem (Elizabeth Douville)
- Genesys Capital (Jamie Stiff)
- Forbion Capital Partners (Marco Boorsma)
- New Enterprise Associates
- adMare BioInnovations
- Fonds de solidarite FTQ
- JDRF T1D Fund (Jonathan Behr)
- Anges Quebec Capital
- Tarnagulla Ventures
- Accel-Rx Health Sciences Accelerator
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs